New drug combo tested in kids fighting aggressive skin cancer
NCT ID NCT00539591
Summary
This study tested a combination of two drugs, temozolomide and peginterferon, to see how well they work in children with high-risk or advanced melanoma. The goal was to see if the treatment could shrink tumors and prevent the cancer from coming back. Children were placed in different treatment groups based on how far their cancer had spread, with some receiving a year of treatment after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rady Children's Hospital
San Diego, California, 92123, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
The Children's Cancer Hospital at UT M.D. Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.